Menu Search
Equities

Coloplast A/S

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CLPBF:PKL

Coloplast A/S

Actions
  • Price (USD)73.87
  • Today's Change-3.15 / -4.08%
  • Shares traded400.00
  • 1 Year change-32.31%
  • Beta0.5560
Data delayed at least 15 minutes, as of Mar 03 2026 14:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in DKKIncome statement in DKKView more

Year on year Coloplast A/S had net income fall -28.03% from 5.05bn to 3.64bn despite a 3.12% increase in revenues from 27.03bn to 27.87bn. An increase in the selling, general and administrative costs as a percentage of sales from 34.52% to 34.65% was a component in the falling net income despite rising revenues.
Gross margin67.87%
Net profit margin14.30%
Operating margin25.58%
Return on assets8.21%
Return on equity27.26%
Return on investment10.44%
More ▼

Cash flow in DKKView more

In 2025, Coloplast A/S increased its cash reserves by 20.18%, or 159.00m. The company earned 6.65bn from its operations for a Cash Flow Margin of 23.84%. In addition the company used 1.25bn on investing activities and also paid 5.19bn in financing cash flows.
Cash flow per share24.23
Price/Cash flow per share18.67
Book value per share61.25
Tangible book value per share-72.65
More ▼

Balance sheet in DKKView more

Coloplast A/S has a Debt to Total Capital ratio of 64.51%, a lower figure than the previous year's 111.97%.
Current ratio1.30
Quick ratio0.8122
Total debt/total equity1.82
Total debt/total capital0.6451
More ▼

Growth rates in DKK

SmartText is unavailable
Div yield(5 year avg)2.66%
Div growth rate (5 year)5.02%
Payout ratio (TTM)129.96%
EPS growth(5 years)-3.90
EPS (TTM) vs
TTM 1 year ago		-18.39
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.